SCHEMBL3563751

SCHEMBL3563751

CC(C)(C)OC(=O)N1CCN(c2nnnn2-c2cccc(N)n2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.48
MAP4K4 O95819 1/20 0.45
SMARCA2 P51531 1/20 0.45
SMARCA4 P51532 1/20 0.45
PBRM1 Q86U86 1/20 0.45
CKS1B P61024 2/20 0.44
SKP1 P63208 2/20 0.44
SKP2 Q13309 2/20 0.44
ADORA2A P29274 3/20 0.44
ADORA1 P30542 1/20 0.44
GBA1 P04062 2/20 0.42
PTPN11 Q06124 1/20 0.42
PARP1 P09874 1/20 0.42
ADORA3 P0DMS8 1/20 0.41
GPR119 Q8TDV5 1/20 0.41
ACHE P22303 2/20 0.41
PIK3CA P42336 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3569090 0.88 ALDH1A1 (0.49) ALDH1A1MAP4K4SMARCA2SMARCA4PBRM1
SCHEMBL3553875 0.88 ALDH1A1 (0.48) ALDH1A1MAP4K4SMARCA2SMARCA4PBRM1
SCHEMBL458906 0.84 MAP4K4 (0.60) ALDH1A1MAP4K4SMARCA2SMARCA4PBRM1
SCHEMBL13119850 0.83 ALDH1A1 (0.50) ALDH1A1MAP4K4SMARCA2SMARCA4PBRM1
SCHEMBL3563555 0.83 GPR119 (0.58) ALDH1A1SMARCA2SMARCA4PBRM1CKS1B
SCHEMBL23104148 0.80 CKS1B (0.59) ALDH1A1MAP4K4SMARCA2SMARCA4PBRM1
SCHEMBL13117069 0.77 ALDH1A1 (0.62) ALDH1A1GPR119SMN1; SMN2LMNAMAPT
SCHEMBL13117065 0.76 GPR119 (0.59) ALDH1A1CKS1BSKP1SKP2GBA1
SCHEMBL461584 0.75 CKS1B (0.62) ALDH1A1MAP4K4SMARCA2SMARCA4PBRM1
SCHEMBL13117070 0.75 ALDH1A1 (0.56) ALDH1A1GPR119SMN1; SMN2LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7807676-B2 Diketo-Piperazine and Piperidine derivatives as antiviral agents BRISTOL-MYERS SQUIBB COMPANY (US) 2010-10-05 US disclosed
US-20080139572-A1 DIKETO-PIPERAZINE AND PIPERIDINE DERIVATIVES AS ANTIVIRAL AGENTS BRISTOL-MYERS SQUIBB COMPANY 2008-06-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080139572-A1 DIKETO-PIPERAZINE AND PIPERIDINE DERIVATIVES AS ANTIVIRAL AGENTS EIF2AK2, DCK, MAVS ALDH1A1 1424/4885MAP4K4 320/4885SMARCA2 3930/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.